NCT02473393View on ClinicalTrials.gov

A Clinical Trial to Assess Three Different Doses of OPS-2071 in Patients With Bacterial Enteritis

PHASE2CompletedINTERVENTIONAL
Enrollment

43

Participants

Timeline

Start Date

August 20, 2015

Primary Completion Date

March 14, 2017

Study Completion Date

March 14, 2017

Conditions
Bacterial Enteritis
Interventions
DRUG

OPS-2071 tablet

Trial Locations (3)

Unknown

Kanto, Region

Singapore

Seoul

Sponsors
All Listed Sponsors
lead

Otsuka Pharmaceutical Co., Ltd.

INDUSTRY